Isoniazid (Isonicotinic Acid Hydrazide, INH)



Isoniazid (Isonicotinic Acid Hydrazide, INH)





(eye soe nye’ a zid)

Isotamine (CAN), Nydrazid

PREGNANCY CATEGORY C


Drug class

Antituberculotic


Therapeutic Actions

Bactericidal: Interferes with lipid and nucleic acid biosynthesis in actively growing tubercle bacilli.



Indications



  • TB, all forms in which organisms are susceptible


  • Prophylaxis in specific patients who are tuberculin reactors or household members of recently diagnosed tuberculars or who are considered to be high risk (patients with HIV, IV drug users, recent converters [5 mm or more increase on skin test within 2 yr in patients younger than 35 yr or 15 mm or more increase in patients older than 35 yr] and children younger than 4 yr with 10 mm or more induration on purified protein derivative tuberculin skin test)



Available Forms

Tablets—100, 300 mg; syrup—50 mg/5 mL; injection—100 mg/mL


Dosages

Adults



  • Treatment of active TB: 5 mg/kg/day (up to 300 mg) PO in a single dose, with other effective drugs or 15 mg/kg (up to 900 mg) PO two or three times per week. “First-line treatment” is considered to be 300 mg INH plus 600 mg rifampin, each given in a single daily oral dose. Consult manufacturer’s guidelines for other possible combinations.


  • Prophylaxis for TB: 300 mg/day PO in a single dose.

Concomitant administration of 10–50 mg/day PO of pyridoxine is recommended for those who are malnourished or predisposed to neuropathy (alcoholics, diabetics).

Pediatric patients

Jul 21, 2016 | Posted by in NURSING | Comments Off on Isoniazid (Isonicotinic Acid Hydrazide, INH)

Full access? Get Clinical Tree

Get Clinical Tree app for offline access